Andrew Bae

514 total citations
18 papers, 401 citations indexed

About

Andrew Bae is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Andrew Bae has authored 18 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in Andrew Bae's work include HIV/AIDS drug development and treatment (10 papers), Hepatitis C virus research (6 papers) and HIV Research and Treatment (3 papers). Andrew Bae is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), Hepatitis C virus research (6 papers) and HIV Research and Treatment (3 papers). Andrew Bae collaborates with scholars based in United States, Sweden and Switzerland. Andrew Bae's co-authors include Michael D. Miller, Jeanette Harris, Hongmei Mo, Michael Grimley, Gregory E. Chittick, Marion E. Morrison, Thomas M. Brundage, Joanne Kurtzberg, Vinod K. Prasad and Roy F. Chemaly and has published in prestigious journals such as Gastroenterology, Journal of Colloid and Interface Science and Journal of Clinical Microbiology.

In The Last Decade

Andrew Bae

17 papers receiving 392 citations

Peers

Andrew Bae
Jose A. Garcia-Rivera United States
Dennis Revie United States
Roberto Fernandez-Larsson United States
Peter Gowland Switzerland
P Almi Italy
Daitze Wu China
Philip D. Yin United States
Jochen M. Wettengel Germany
Alex S. Hartlage United States
Ralf Schilling United Kingdom
Jose A. Garcia-Rivera United States
Andrew Bae
Citations per year, relative to Andrew Bae Andrew Bae (= 1×) peers Jose A. Garcia-Rivera

Countries citing papers authored by Andrew Bae

Since Specialization
Citations

This map shows the geographic impact of Andrew Bae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Bae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Bae more than expected).

Fields of papers citing papers by Andrew Bae

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Bae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Bae. The network helps show where Andrew Bae may publish in the future.

Co-authorship network of co-authors of Andrew Bae

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Bae. A scholar is included among the top collaborators of Andrew Bae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Bae. Andrew Bae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bae, Andrew, et al.. (2024). Probing the Self-Assembly dynamics of cellulose nanocrystals by X-ray photon correlation spectroscopy. Journal of Colloid and Interface Science. 683(Pt 2). 1077–1086. 1 indexed citations
2.
3.
Bae, Andrew, et al.. (2022). Patient-reported dissatisfaction following second side in staged bilateral total knee arthroplasty: A systematic review. World Journal of Orthopedics. 13(11). 1029–1037. 1 indexed citations
4.
Bae, Andrew & Susu Xu. (2022). Discovering and Understanding Algorithmic Biases in Autonomous Pedestrian Trajectory Predictions. 1155–1161. 5 indexed citations
5.
6.
Bae, Andrew, Ricardo Henao, Ayako Suzuki, et al.. (2018). 358 - Statin Use and Liver Injury in Nonalcoholic Fatty Liver Disease: Results of a Paired Clinical and Gene Expression Profile Analysis. Gastroenterology. 154(6). S–1085. 1 indexed citations
7.
Grimley, Michael, Roy F. Chemaly, Janet A. Englund, et al.. (2017). Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial. Biology of Blood and Marrow Transplantation. 23(3). 512–521. 118 indexed citations
8.
Bae, Andrew, Phiroze Sethna, Thomas M. Brundage, et al.. (2016). Role of Adenovirus Species and Type on Virologic Response to Brincidofovir. Biology of Blood and Marrow Transplantation. 22(3). S55–S55. 2 indexed citations
9.
Dvory‐Sobol, Hadas, Kelly A. Wong, Karin S. Ku, et al.. (2012). Characterization of Resistance to the Protease Inhibitor GS-9451 in Hepatitis C Virus-Infected Patients. Antimicrobial Agents and Chemotherapy. 56(10). 5289–5295. 23 indexed citations
10.
Bae, Andrew, Karin S. Ku, Michael D. Miller, Hongmei Mo, & Evguenia S. Svarovskaia. (2011). Allele-Specific Real-Time PCR System for Detection of Subpopulations of Genotype 1a and 1b Hepatitis C NS5B Y448H Mutant Viruses in Clinical Samples. Journal of Clinical Microbiology. 49(9). 3168–3174. 7 indexed citations
11.
Harris, Jeanette, Andrew Bae, Christy M. Hebner, et al.. (2011). 1225 CHARACTERIZATION OF VIRAL RESISTANCE MUTATIONS IN GENOTYPE 1 HCV PATIENTS RECEIVING COMBINATION THERAPY WITH A PROTEASE INHIBITOR AND A POLYMERASE INHIBITOR WITH OR WITHOUT RIBAVIRIN. Journal of Hepatology. 54. S484–S484. 6 indexed citations
12.
Bae, Andrew, Xiaole Qi, Jeanette Harris, et al.. (2010). Natural variation in drug susceptibility to HCV polymerase inhibitors in treatment-naïve HCV patient isolates. Journal of Viral Hepatitis. 18(12). 861–870. 11 indexed citations
13.
Lawitz, E.J., Bradley Vince, Nicole Grunenberg, et al.. (2010). 2008 DOSE-RANGING, THREE-DAY MONOTHERAPY STUDY OF THE HCV NS3 PROTEASE INHIBITOR GS-9256. Journal of Hepatology. 52. S466–S467. 10 indexed citations
14.
Bae, Andrew, Xiaoping Qi, Xiaowu Chen, et al.. (2010). Susceptibility of Treatment-Naive Hepatitis C Virus (HCV) Clinical Isolates to HCV Protease Inhibitors. Antimicrobial Agents and Chemotherapy. 54(12). 5288–5297. 67 indexed citations
15.
Qi, Xiaoping, Andrew Bae, Shan Liu, et al.. (2008). Development of a replicon-based phenotypic assay for assessing the drug susceptibilities of HCV NS3 protease genes from clinical isolates. Antiviral Research. 81(2). 166–173. 34 indexed citations
16.
Borroto–Esoda, Katyna, et al.. (2007). Baseline Genotype as a Predictor of Virological Failure to Emtricitabine or Stavudine in Combination with Didanosine and Efavirenz. AIDS Research and Human Retroviruses. 23(8). 988–995. 27 indexed citations
17.
Svarovskaia, Evguenia S., Nicolas Margot, Andrew Bae, et al.. (2007). Low-Level K65R Mutation in HIV-1 Reverse Transcriptase of Treatment-Experienced Patients Exposed to Abacavir or Didanosine. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(2). 174–180. 31 indexed citations
18.
Svarovskaia, Evguenia S., Michael J. Moser, Andrew Bae, et al.. (2006). MultiCode-RTx Real-Time PCR System for Detection of Subpopulations of K65R Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutant Viruses in Clinical Samples. Journal of Clinical Microbiology. 44(11). 4237–4241. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jose A. Garcia-Rivera Breakdown of academic impact, for papers by Dennis Revie Breakdown of academic impact, for papers by Roberto Fernandez-Larsson Breakdown of academic impact, for papers by Peter Gowland Breakdown of academic impact, for papers by P Almi Breakdown of academic impact, for papers by Daitze Wu Breakdown of academic impact, for papers by Philip D. Yin Breakdown of academic impact, for papers by Jochen M. Wettengel Breakdown of academic impact, for papers by Alex S. Hartlage Breakdown of academic impact, for papers by Ralf Schilling
Rankless by CCL
2026